ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 1390 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 1390; 2) Community: the network communities that were significantly associated with the response to NSC 1390; 3) Molecule: the relationships between components within communities and NSC 1390; 4) MDR: the compounds that were significantly associated with the NSC 1390.

NSC Compound Enrichment Correlation
NSC 711014 Null 0.0162638908166157 0.03384839
NSC 722218 Varacin trifluoroacetate salt 0.0162638908166157 0.33528827
NSC 723741 Diethyl N-[4-[(3-phenyl-5,7-diaminoquinoxalin-2-yl)hydroxy]benzoyl]- L-glutamate 0.0162638908166157 0.030163884
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.0162638908166157 0.26961963
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0162638908166157 -0.012299258
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0162638908166157 0.22840109
NSC 630684 8-Quinolinecarboxaldehyde, 2-(2,4-dinitrophenyl)-2-methyl- hydrazone 0.0163859626459253 -0.19040083
NSC 622958 Null 0.0163859626459254 0.23345916
NSC 106486 Formycin B 0.0171490505199913 0.4875281
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0171490505199913 0.38989763
Total:81  Current:26    [First] [Prev] [Next] [Last]